Pressure Bioscience (PBIO) Meets Ohio State University. Pressure Testing on Food and Beverages.
OHIO STATE INSTALLS, COMMISSIONS NEW PILOT-SCALE ULTRA-SHEAR TECHNOLOGY EQUIPMENT FOR LIQUID FOODS AND BEVERAGES PROCESSING
Past News From Ohio State Worth Reviewing.
June 2022: Study Completed...
Adding Pressure BioSciences (PBIO) $0.80 to Watch List.
Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues.
Photo Ric Schumacher CEO
SHORT TERM CHART
LIVE QUOTE
When we say "finally" meets revenues, that's...
Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.
CBD Supply MD, a Leading Maryland-Based CBD Retailer, to Introduce PBIO's UltraShear Processed, Best-in-Class Nanoemulsified CBD Products Across the Multi-State Mid-Atlantic Region
SOUTH EASTON, MA...
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in these turbulent...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers.
Definitely NOT for traders or...
Topical PTSD Drug Poised for Human Trials.
In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...
Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?
Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come.
Society Pass currently has its fingers in the Travel, Fashion,...
Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?
We Think Yes..!
With the year just finished ringing in $17.8 million in revenues, versus a market capitalization of just $3 million - we actually...
The Ketamine Endgame. Silo Pharmaceutical (SILO).
James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference.
Dr....
Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.
If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...















